Investigating the Impact of Social Determinants of Health on Diagnostic Delays and Access to Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis

Authors

Rui Li
Qiuhao Lu
Andrew Wen
Jinlian Wang
Sunyang Fu
Xiaoyang Ruan
Liwei Wang
Hongfang Liu

Language

English

Publication Date

1-1-2025

Journal

AMIA Summits on Translational Science Proceedings

PMID

40502238

PMCID

PMC12150710

PubMedCentral® Posted Date

6-10-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Idiopathic pulmonary fibrosis (IPF) is a rare disease that is challenging to diagnose. Patients with IPF often spend years awaiting a diagnosis after the onset of initial respiratory symptoms, and only a small percentage receive antifibrotic treatment. In this study, we examine the associations between social determinants of health (SDoH) and two critical factors: time to IPF diagnosis following the onset of initial respiratory symptoms, and whether the patient receives antifibrotic treatment. To approximate individual SDoH characteristics, we extract demographic-specific averages from zip code-level data using the American Community Survey (via the U.S. Census Bureau API). Two classification models are constructed, including logistic regression and XGBoost classification. The results indicate that for time-to-diagnosis, the top three SDoH factors are education, gender, and insurance coverage. Patients with higher education levels and better insurance are more likely to receive a quicker diagnosis, with males having an advantage over females. For antifibrotic treatment, the top three SDoH factors are insurance, gender, and race. Patients with better insurance coverage are more likely to receive antifibrotic treatment, with males and White patients having an advantage over females and patients of other ethnicities. This research may help address disparities in the diagnosis and treatment of IPF related to socioeconomic status.

Published Open-Access

yes

Recommended Citation

Li, Rui; Lu, Qiuhao; Wen, Andrew; et al., "Investigating the Impact of Social Determinants of Health on Diagnostic Delays and Access to Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis" (2025). Faculty, Staff and Student Publications. 662.
https://digitalcommons.library.tmc.edu/uthshis_docs/662